The Potential Role of Proinflammatory Cytokines and Complement Components in the Development of Drug-Induced Neuropathy in Patients with Multiple Myeloma

The launch of novel chemotherapeutic agents—in particular, proteasome inhibitors and immunomodulatory drugs—dramatically changed multiple myeloma (MM) therapy, improving the response rate and prolonging progression-free survival. However, none of the anti-MM drugs are deprived of side effects. Perip...

Full description

Bibliographic Details
Main Authors: Karolina Łuczkowska, Magdalena Rutka, Dorota Rogińska, Edyta Paczkowska, Bartłomiej Baumert, Sławomir Milczarek, Martyna Górska, Piotr Kulig, Bogumiła Osękowska, Michał Janowski, Krzysztof Safranow, Krzysztof Sommerfeld, Ewa Borowiecka, Piotr Zawodny, Anna Koclęga, Grzegorz Helbig, Bogusław Machaliński
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/19/4584